Design of readers for pathological PTM proteoforms in Alzheimer’s disease
Alzheimer’s disease (AD) is characterized by heterogeneous Tau phosphorylation and aberrant amyloid-β (Aβ) processing, yet molecular tools that distinguish closely related molecular states of tau and Aβ with predefined specificity remain difficult to develop. Here, we designed de novo protein readers targeting three di...